Loading
A phase 3 trial of Leucovorin and Tegafur, gimeracil and oteracil in Colorectal cancer, run by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, completed.
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery is a phase 3 interventional study registered as NCT00660894 by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, with 1535 participants recorded, started 2008-04 and reaching its primary completion in 2012-06. Interventions recorded: folinate calcium, tegafur-uracil, tegafur-gimeracil-oteracil potassium. Conditions recorded: Colorectal Cancer.
Linked to the drug Tegafur, gimeracil and oteracil because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Tegafur, gimeracil and oteracil (S-1), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.